118 results
Page 4 of 6
8-K/A
EX-10.1
f7zsy2g
6 Mar 19
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-10.1
4ae45lzg
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
424B5
gpge 6cb0
19 Feb 19
Prospectus supplement for primary offering
8:39am
8-K
EX-99.2
0s0erie clw
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
bekfidutcivpzw82yzbs
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-99.1
o49dc awm8166wcz6
7 Jan 19
Other Events
7:01am
8-K
EX-10.1
gg7424j9psu451
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
h3i1 cxj6lnu1
10 Dec 18
Other Events
2:07pm
8-K
EX-99.2
s4bttqro3t8e820qn0ow
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
aypjvsq z4z7q
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
kex0 nyh4c2d5ih5fj
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
33vaqsb4
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.2
swm4jhfbw7ncrd
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
5yxi ei5vx5og988d
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am